Literature DB >> 4741927

A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.

A J Schutt, R G Hahn, R J Reitemeier, C G Moertel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4741927

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  1 in total

1.  Phase II trial of intravenous melphalan in advanced colorectal carcinoma.

Authors:  D F Moore; R Pazdur; J L Abbruzzese
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.